Cubist Hits Hospira With Patent Suit Over Generic Cubicin

Law360, New York (July 10, 2012, 2:41 PM EDT) -- Cubist Pharmaceuticals Inc. lodged a suit against Hospira Inc. in Delaware federal court on Monday, claiming the generic-drug maker infringed a patent covering its drug Cubicin, an IV antibiotic used to treat skin and blood infections.

Lexington, Mass.-based Cubist filed the suit after Hospira allegedly sought U.S. Food and Drug Administration approval to make and market a generic version of Cubicin in violation of Cubist’s patent rights.

“Hospira’s submission of [abbreviated new drug application] No. 202587 for the purpose of obtaining approval to engage in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.